These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 2046075

  • 1. Oral contraceptives and coronary heart disease.
    Wynn V.
    J Reprod Med; 1991 Mar; 36(3 Suppl):219-25. PubMed ID: 2046075
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 3. [Metabolic risks of oral contraception].
    Monier L.
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [Abstract] [Full Text] [Related]

  • 4. Oral contraceptives and metabolic risk markers for coronary heart disease.
    Crook D, Godsland IF, Wynn V.
    Int J Fertil; 1991 Feb; 36 Suppl 1():38-46. PubMed ID: 1678380
    [Abstract] [Full Text] [Related]

  • 5. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 6. Pill formulations and their effect on lipid and carbohydrate metabolism.
    Brooks PG.
    J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707
    [Abstract] [Full Text] [Related]

  • 7. [Oral contraceptives and metabolic changes].
    Lara Ricalde R, Aznar Ramos R.
    Ginecol Obstet Mex; 1986 Aug; 54():212-5. PubMed ID: 3781292
    [Abstract] [Full Text] [Related]

  • 8. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Aug; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 9. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U, Dubois M.
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [Abstract] [Full Text] [Related]

  • 10. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 11. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R, Hilliquin P.
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [Abstract] [Full Text] [Related]

  • 12. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC.
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [Abstract] [Full Text] [Related]

  • 13. [Women and ischemic cardiopathy].
    Assmann G, Davignon J, Fernández Cruz A, Gotto AM, Jacotot B, Lewis B, Paoletti R.
    Rev Clin Esp; 1989 Oct; 185(6):308-15. PubMed ID: 2695994
    [Abstract] [Full Text] [Related]

  • 14. Women, lipoproteins and cardiovascular disease risk.
    LaRosa JC.
    Can J Cardiol; 1990 May; 6 Suppl B():23B-29B. PubMed ID: 2188715
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG.
    Int J Fertil; 1989 May; 34 Suppl():40-9. PubMed ID: 2576258
    [Abstract] [Full Text] [Related]

  • 16. [Oral contraception, glucid metabolism and monitoring criteria].
    Gaspard U.
    Contracept Fertil Sex (Paris); 1988 Feb; 16(2):113-8. PubMed ID: 12342000
    [Abstract] [Full Text] [Related]

  • 17. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy.
    Burkman RT.
    Fertil Steril; 1988 May; 49(5 Suppl 2):39S-50S. PubMed ID: 3282934
    [Abstract] [Full Text] [Related]

  • 18. Metabolic effects of oral contraceptives: fact vs. fiction.
    Contracept Rep; 1996 Jan; 6(6):4-14. PubMed ID: 12320011
    [Abstract] [Full Text] [Related]

  • 19. [Combined estrogen-progestagen contraception and glucid and water-sodium metabolism].
    Belaisch J, Hommais-loufrani B.
    Contracept Fertil Sex (Paris); 1988 Feb; 16(2):3-7. PubMed ID: 12342001
    [Abstract] [Full Text] [Related]

  • 20. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D, Godsland IF, Wynn V.
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.